Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation


Onat A., Can G., Hergenc G., Yazici M., Karabulut A. , Albayrak S.

INTERNATIONAL JOURNAL OF OBESITY, cilt.31, ss.1119-1125, 2007 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 31 Konu: 7
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1038/sj.ijo.0803552
  • Dergi Adı: INTERNATIONAL JOURNAL OF OBESITY
  • Sayfa Sayıları: ss.1119-1125

Özet

Objectives: To investigate the role of serum apolipoprotein (apo) B levels in predicting metabolic syndrome (MS), hypertension, atherogenic dyslipidemia and type II diabetes.